5.92
0.12 (2.07%)
| Previous Close | 5.80 |
| Open | 5.85 |
| Volume | 244,148 |
| Avg. Volume (3M) | 112,307 |
| Market Cap | 274,230,112 |
| Price / Sales | 6.84 |
| Price / Book | 16.33 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Profit Margin | -15.10% |
| Operating Margin (TTM) | -12.92% |
| Diluted EPS (TTM) | -0.120 |
| Quarterly Revenue Growth (YOY) | 17.50% |
| Total Debt/Equity (MRQ) | 22.83% |
| Current Ratio (MRQ) | 2.44 |
| Levered Free Cash Flow (TTM) | 1.05 M |
| Return on Assets (TTM) | -13.09% |
| Return on Equity (TTM) | -29.87% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | KORU Medical Systems, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | -3.0 |
| Price Volatility | -4.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | -0.40 |
|
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 7.65% |
| % Held by Institutions | 51.77% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MANKO JOSEPH M. JR. | - | 5.80 | -41,000 | -237,800 |
| Aggregate Net Quantity | -41,000 | |||
| Aggregate Net Value ($) | -237,800 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 5.80 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MANKO JOSEPH M. JR. | Director | 26 Nov 2025 | Disposed (-) | 41,000 | 5.80 | 237,800 |
| Date | Type | Details |
|---|---|---|
| 17 Nov 2025 | Announcement | KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 |
| 13 Nov 2025 | Announcement | KORU Medical Systems to Participate in Upcoming Investor Conferences |
| 12 Nov 2025 | Announcement | KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance |
| 04 Nov 2025 | Announcement | KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems |
| 22 Oct 2025 | Announcement | KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 |
| 18 Sep 2025 | Announcement | ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |